BusinessOcera to Present at the 18th Annual BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 2, 2016, 9:20 PM UTC
BusinessOcera Announces Complete Plasma Data From Pilot Phase 1 Study for Orally-Available OCR-002 in Development for the Prevention of Chronic Hepatic EncephalopathyBy Nasdaq OMXJan 8, 2016, 2:05 PM UTC
BusinessOcera Appoints Dr. Stan Bukofzer as Chief Medical OfficerBy Nasdaq OMXJan 7, 2016, 9:05 PM UTC
